 Stig Somme
Concepts (170)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tracheomalacia | 4 | 2022 | 18 | 1.180 |
Why?
| | Laparoscopy | 3 | 2018 | 395 | 0.840 |
Why?
| | Trachea | 4 | 2021 | 223 | 0.780 |
Why?
| | Thoracoscopy | 2 | 2019 | 49 | 0.780 |
Why?
| | Duodenal Obstruction | 1 | 2018 | 5 | 0.620 |
Why?
| | Duodenostomy | 1 | 2018 | 5 | 0.620 |
Why?
| | Duodenum | 1 | 2018 | 62 | 0.600 |
Why?
| | Prenatal Diagnosis | 2 | 2016 | 163 | 0.560 |
Why?
| | Appendicitis | 3 | 2019 | 112 | 0.520 |
Why?
| | Pyloric Stenosis | 1 | 2015 | 3 | 0.490 |
Why?
| | Pylorus | 1 | 2015 | 13 | 0.480 |
Why?
| | Congenital Abnormalities | 1 | 2015 | 72 | 0.480 |
Why?
| | Early Diagnosis | 1 | 2015 | 217 | 0.440 |
Why?
| | Bronchoscopy | 4 | 2021 | 196 | 0.380 |
Why?
| | Tracheoesophageal Fistula | 2 | 2022 | 30 | 0.370 |
Why?
| | Referral and Consultation | 1 | 2015 | 632 | 0.360 |
Why?
| | Digestive System Surgical Procedures | 3 | 2006 | 91 | 0.340 |
Why?
| | Metronidazole | 2 | 2019 | 19 | 0.300 |
Why?
| | Treatment Outcome | 11 | 2023 | 9051 | 0.300 |
Why?
| | Appendectomy | 2 | 2017 | 66 | 0.300 |
Why?
| | Intussusception | 1 | 2006 | 28 | 0.260 |
Why?
| | Specialties, Surgical | 1 | 2007 | 67 | 0.260 |
Why?
| | Gastroschisis | 2 | 2021 | 15 | 0.240 |
Why?
| | Fetal Diseases | 2 | 2016 | 146 | 0.230 |
Why?
| | Retrospective Studies | 10 | 2023 | 12521 | 0.220 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2004 | 154 | 0.220 |
Why?
| | Infant, Newborn | 9 | 2022 | 5038 | 0.210 |
Why?
| | Hirschsprung Disease | 1 | 2004 | 90 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2023 | 18 | 0.210 |
Why?
| | Airway Obstruction | 2 | 2016 | 160 | 0.210 |
Why?
| | Pneumothorax | 1 | 2023 | 40 | 0.210 |
Why?
| | Colon | 1 | 2004 | 232 | 0.210 |
Why?
| | Child, Preschool | 10 | 2020 | 9120 | 0.200 |
Why?
| | Tracheobronchomalacia | 1 | 2022 | 12 | 0.200 |
Why?
| | Infant | 10 | 2022 | 7945 | 0.200 |
Why?
| | Nobel Prize | 1 | 2001 | 4 | 0.190 |
Why?
| | Intestinal Atresia | 1 | 2021 | 15 | 0.190 |
Why?
| | Polytetrafluoroethylene | 1 | 2021 | 25 | 0.190 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2021 | 27 | 0.180 |
Why?
| | Child | 14 | 2023 | 18408 | 0.180 |
Why?
| | Female | 18 | 2021 | 59347 | 0.180 |
Why?
| | Esophageal Atresia | 1 | 2020 | 23 | 0.180 |
Why?
| | Recurrence | 2 | 2023 | 925 | 0.180 |
Why?
| | Catheterization, Central Venous | 1 | 2001 | 83 | 0.170 |
Why?
| | Humans | 29 | 2023 | 114078 | 0.170 |
Why?
| | Bronchiectasis | 1 | 2020 | 106 | 0.160 |
Why?
| | Operative Time | 1 | 2018 | 106 | 0.150 |
Why?
| | Ovarian Cysts | 1 | 2017 | 8 | 0.150 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 135 | 0.150 |
Why?
| | Vascular Diseases | 1 | 2020 | 233 | 0.150 |
Why?
| | Ovarian Diseases | 1 | 2017 | 12 | 0.150 |
Why?
| | Torsion Abnormality | 1 | 2017 | 18 | 0.150 |
Why?
| | Abdominal Injuries | 1 | 2019 | 107 | 0.140 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2022 | 333 | 0.140 |
Why?
| | Cefoxitin | 1 | 2017 | 8 | 0.140 |
Why?
| | Ceftriaxone | 1 | 2017 | 18 | 0.140 |
Why?
| | beta-Lactams | 1 | 2017 | 27 | 0.140 |
Why?
| | Acute Disease | 1 | 2019 | 909 | 0.140 |
Why?
| | Anesthesia | 1 | 2018 | 117 | 0.130 |
Why?
| | Male | 11 | 2020 | 55418 | 0.130 |
Why?
| | Feasibility Studies | 1 | 2019 | 735 | 0.130 |
Why?
| | Postoperative Complications | 1 | 2007 | 2122 | 0.130 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 249 | 0.130 |
Why?
| | Pyloric Stenosis, Hypertrophic | 1 | 2015 | 8 | 0.120 |
Why?
| | Surgery Department, Hospital | 1 | 2015 | 22 | 0.120 |
Why?
| | Gastroesophageal Reflux | 2 | 2010 | 229 | 0.120 |
Why?
| | Length of Stay | 2 | 2019 | 957 | 0.120 |
Why?
| | Enteral Nutrition | 3 | 2023 | 157 | 0.120 |
Why?
| | Fetoscopy | 1 | 2014 | 28 | 0.120 |
Why?
| | Fetofetal Transfusion | 1 | 2014 | 21 | 0.110 |
Why?
| | Bronchogenic Cyst | 1 | 2013 | 6 | 0.110 |
Why?
| | Postoperative Care | 1 | 2015 | 223 | 0.110 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2015 | 176 | 0.100 |
Why?
| | Genetic Testing | 1 | 2015 | 381 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2019 | 4392 | 0.100 |
Why?
| | Pregnancy | 4 | 2016 | 5503 | 0.100 |
Why?
| | Adolescent | 8 | 2023 | 17811 | 0.090 |
Why?
| | Gastric Emptying | 1 | 2010 | 39 | 0.080 |
Why?
| | Fundoplication | 1 | 2010 | 51 | 0.080 |
Why?
| | Stomach | 1 | 2010 | 102 | 0.080 |
Why?
| | Prevalence | 1 | 2015 | 2248 | 0.080 |
Why?
| | Incidence | 1 | 2015 | 2314 | 0.080 |
Why?
| | Thoracotomy | 2 | 2023 | 73 | 0.080 |
Why?
| | Estrogen Receptor beta | 1 | 2008 | 33 | 0.070 |
Why?
| | Preoperative Care | 1 | 2010 | 319 | 0.070 |
Why?
| | Rhabdomyosarcoma | 1 | 2008 | 55 | 0.070 |
Why?
| | Tamoxifen | 1 | 2008 | 190 | 0.070 |
Why?
| | Ontario | 1 | 2007 | 77 | 0.070 |
Why?
| | Health Facility Size | 1 | 2006 | 12 | 0.070 |
Why?
| | Hospitals, Special | 1 | 2006 | 10 | 0.070 |
Why?
| | Colostomy | 1 | 2004 | 26 | 0.060 |
Why?
| | Laparotomy | 1 | 2004 | 101 | 0.060 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2004 | 75 | 0.060 |
Why?
| | Ultrasonography, Prenatal | 2 | 2016 | 238 | 0.050 |
Why?
| | Chest Tubes | 1 | 2023 | 27 | 0.050 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2023 | 39 | 0.050 |
Why?
| | Comorbidity | 2 | 2020 | 1447 | 0.050 |
Why?
| | Catheter Ablation | 1 | 2005 | 287 | 0.050 |
Why?
| | Esophageal Stenosis | 1 | 2002 | 45 | 0.050 |
Why?
| | Physiology | 1 | 2001 | 9 | 0.050 |
Why?
| | History, 19th Century | 1 | 2001 | 54 | 0.050 |
Why?
| | Sweden | 1 | 2001 | 65 | 0.050 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2004 | 496 | 0.050 |
Why?
| | Evidence-Based Practice | 1 | 2023 | 185 | 0.050 |
Why?
| | Sutures | 1 | 2021 | 50 | 0.050 |
Why?
| | Catheterization | 1 | 2002 | 158 | 0.050 |
Why?
| | Academies and Institutes | 1 | 2001 | 44 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2008 | 2173 | 0.050 |
Why?
| | Glioma | 1 | 2004 | 285 | 0.040 |
Why?
| | History, 20th Century | 1 | 2001 | 265 | 0.040 |
Why?
| | Prognosis | 2 | 2004 | 3315 | 0.040 |
Why?
| | Esophagus | 1 | 2002 | 224 | 0.040 |
Why?
| | Bacteroides fragilis | 1 | 2019 | 11 | 0.040 |
Why?
| | Intestines | 1 | 2023 | 325 | 0.040 |
Why?
| | Monte Carlo Method | 1 | 2019 | 136 | 0.040 |
Why?
| | Area Under Curve | 1 | 2019 | 273 | 0.040 |
Why?
| | Infant, Premature | 1 | 2022 | 478 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 300 | 0.040 |
Why?
| | Anesthetics | 1 | 2018 | 54 | 0.040 |
Why?
| | Perioperative Care | 1 | 2018 | 126 | 0.030 |
Why?
| | Adult | 2 | 2015 | 30394 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2004 | 2540 | 0.030 |
Why?
| | Embolization, Therapeutic | 1 | 2019 | 178 | 0.030 |
Why?
| | Abdominal Abscess | 1 | 2017 | 25 | 0.030 |
Why?
| | Drug Substitution | 1 | 2017 | 46 | 0.030 |
Why?
| | Fertility | 1 | 2017 | 128 | 0.030 |
Why?
| | Cost Savings | 1 | 2017 | 74 | 0.030 |
Why?
| | Ovary | 1 | 2017 | 190 | 0.030 |
Why?
| | Risk Assessment | 1 | 2004 | 2958 | 0.030 |
Why?
| | Young Adult | 2 | 2023 | 10458 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 2017 | 714 | 0.030 |
Why?
| | Nifedipine | 1 | 2014 | 29 | 0.030 |
Why?
| | Ventricular Dysfunction | 1 | 2014 | 16 | 0.030 |
Why?
| | Ultrasonography | 1 | 2017 | 635 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 544 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2017 | 949 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2016 | 3039 | 0.030 |
Why?
| | Calcium Channel Blockers | 1 | 2014 | 113 | 0.030 |
Why?
| | Resuscitation | 1 | 2016 | 221 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2015 | 232 | 0.030 |
Why?
| | Fetal Therapies | 1 | 2013 | 30 | 0.030 |
Why?
| | Colorado | 1 | 2023 | 4092 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1762 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2273 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1381 | 0.020 |
Why?
| | Cardiomyopathies | 1 | 2014 | 298 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2008 | 1144 | 0.020 |
Why?
| | Radionuclide Imaging | 1 | 2010 | 115 | 0.020 |
Why?
| | Lung | 1 | 2020 | 3521 | 0.020 |
Why?
| | Tumor Stem Cell Assay | 1 | 2008 | 33 | 0.020 |
Why?
| | Prospective Studies | 1 | 2019 | 6198 | 0.020 |
Why?
| | Estrogen Antagonists | 1 | 2008 | 39 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2008 | 285 | 0.020 |
Why?
| | Estrogen Receptor alpha | 1 | 2008 | 121 | 0.020 |
Why?
| | Developmental Disabilities | 1 | 2010 | 236 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 845 | 0.020 |
Why?
| | Estradiol | 1 | 2008 | 450 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2010 | 2388 | 0.010 |
Why?
| | Adenoviridae | 1 | 2004 | 184 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2004 | 287 | 0.010 |
Why?
| | United States | 1 | 2019 | 12144 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 754 | 0.010 |
Why?
| | Survival Analysis | 1 | 2004 | 1206 | 0.010 |
Why?
| | Biopsy | 1 | 2004 | 1024 | 0.010 |
Why?
| | Apoptosis | 1 | 2008 | 2349 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2004 | 830 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2004 | 2699 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2004 | 2550 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 3862 | 0.010 |
Why?
| | Signal Transduction | 1 | 2008 | 4501 | 0.010 |
Why?
|
|
Somme's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|